MiMedx Group (MDXG) is scheduled to report Q3 earnings on October 28, 2026. Analysts estimate EPS of $0.03 and quarterly revenue of $70.54M.
In the most recent quarter (Q2), MiMedx Group reported EPS of $-0.05, missing estimates of $-0.03 by 0.67%. Revenue came in at $64.36M, exceeding the estimate of $63.46M by 0.01%.
MiMedx Group has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, MiMedx Group has averaged an EPS surprise of 0.61% and a revenue surprise of 0.10%.
Earnings Date
Oct 28
EPS Estimate
$0.030
Quarterly Revenue Estimate
$70.54M
Annual Revenue
$355.17M
as of Jun 30
Analyze the earnings history of MiMedx Group using advanced sorting and filters.
The chart below shows MiMedx Group's reported EPS compared to analyst estimates over recent quarters.
The chart below shows MiMedx Group's reported revenue compared to analyst estimates over recent quarters.
MiMedx Group (MDXG) is scheduled to report earnings on October 28, 2026. The last reported earnings were for reported on July 29, 2026 for Q2.
The Actual EPS was $-0.05, which missed the estimate of $-0.03.
The Actual Revenue was $64.36M, which beat the estimate of $63.46M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-0.05 | $-0.03 | -66.7 % |
| Q1 | Apr 29, 2026 | $-0.05 | $-0.04 | -25.0 % |
| Q4 | Feb 25, 2026 | $0.14 | $0.10 | 40.0 % |
| Q3 | Oct 29, 2025 | $0.15 | $0.07 | 114.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $64.36M | $63.46M | 1.42 % |
| Q1 | Apr 29, 2026 | $58.99M | $64.04M | -7.88 % |
| Q4 | Feb 25, 2026 | $118.10M | $105.17M | 12.3 % |
| Q3 | Oct 29, 2025 | $113.73M | $94.75M | 20.0 % |